Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation

Joshi, A; Butle, A; Hait, S; Mishra, R; Trivedi, V; Thorat, R; Choughule, A; Noronha, V; Prabhash, K; Dutt, A

Dutt, A (通讯作者)，Tata Mem Hosp, Adv Ctr Treatment Res Educ Canc ACTREC, Integrated Canc Genom Lab, Navi Mumbai 410210, Maharashtra, India.;Dutt, A (通讯作者)，Homi Bhabha Natl Inst, Training Sch Complex, Mumbai 400094, India.

TRANSLATIONAL ONCOLOGY, 2022; 22 ():

Abstract

Osimertinib, a third-generation EGFR tyrosine kinase inhibitor, shows significant benefit among patients with EGFR T790M mutation at disease progressi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索